2-O-(6-Desoxy-α-L-mannopyranosyl)-(3β,6α,12β)-20-(β-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl-β-D-glucopyranosid
CAS-Nr.
52286-59-6
Bezeichnung:
2-O-(6-Desoxy-α-L-mannopyranosyl)-(3β,6α,12β)-20-(β-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl-β-D-glucopyranosid
Englisch Name:
Ginsenoside Re
Synonyma:
DCR-020;Panaxoside;NSC 308877;ginsenosideb2;GINSENOSIDE RE;Sanchinoside Re;98%byHPLC/CH90650;Re
Ginsenoside Re;Ginsenoside Re-RM;Ginsenoside Re (P)
CBNumber:
CB5210824
Summenformel:
C48H82O18
Molgewicht:
947.17
MOL-Datei:
52286-59-6.mol
2-O-(6-Desoxy-α-L-mannopyranosyl)-(3β,6α,12β)-20-(β-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl-β-D-glucopyranosid Eigenschaften
Schmelzpunkt:
201~203℃
Siedepunkt:
1011.8±65.0 °C(Predicted)
Dichte
1.38±0.1 g/cm3(Predicted)
storage temp.
Inert atmosphere,2-8°C
L?slichkeit
DMSO (Slightly), Methanol (Slightly), Pyridine (Slightly)
pka
12.85±0.70(Predicted)
Aggregatzustand
Solid
Farbe
White to Off-White
InChIKey
PWAOOJDMFUQOKB-WCZZMFLVSA-N
LogP
4.750 (est)
CAS Datenbank
52286-59-6(CAS DataBase Reference)
Sicherheit
Risiko- und Sicherheitserkl?rung
Gefahreninformationscode (GHS)
Kennzeichnung gef?hrlicher
Xn
R-S?tze:
20/21/22
S-S?tze:
26-36
WGK Germany
3
RTECS-Nr.
LY9536700
HS Code
29389090
Bildanzeige (GHS)
Alarmwort
Warnung
Gefahrenhinweise
Code
Gefahrenhinweise
Gefahrenklasse
Abteilung
Alarmwort
Symbol
P-Code
H302
Gesundheitssch?dlich bei Verschlucken.
Akute Toxizit?t oral
Kategorie 4
Warnung
src="/GHS07.jpg" width="20" height="20" />
P264, P270, P301+P312, P330, P501
Sicherheit
P264
Nach Gebrauch gründlich waschen.
P264
Nach Gebrauch gründlich waschen.
P270
Bei Gebrauch nicht essen, trinken oder rauchen.
P301+P312
BEI VERSCHLUCKEN: Bei Unwohlsein GIFTINFORMATIONSZENTRUM/Arzt/... (geeignete Stelle für medizinische Notfallversorgung vom Hersteller/Lieferanten anzugeben) anrufen.
P501
Inhalt/Beh?lter ... (Entsorgungsvorschriften vom Hersteller anzugeben) zuführen.
2-O-(6-Desoxy-α-L-mannopyranosyl)-(3β,6α,12β)-20-(β-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl-β-D-glucopyranosid Chemische Eigenschaften,Einsatz,Produktion Methoden
R-S?tze Betriebsanweisung:
R20/21/22:Gesundheitssch?dlich beim Einatmen,Verschlucken und Berührung mit der Haut.
S-S?tze Betriebsanweisung:
S26:Bei Berührung mit den Augen sofort gründlich mit Wasser abspülen und Arzt konsultieren.
S36:DE: Bei der Arbeit geeignete Schutzkleidung tragen.
Chemische Eigenschaften
White solid
Verwenden
Ginsenoside Re is an extract from ginger, responsible for some of the pharmacological functions. It displays cardiac contractility, anti-ischemic and anti-arrythmic activities.
2-O-(6-Desoxy-α-L-mannopyranosyl)-(3β,6α,12β)-20-(β-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl-β-D-glucopyranosid Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
2-O-(6-Desoxy-α-L-mannopyranosyl)-(3β,6α,12β)-20-(β-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl-β-D-glucopyranosid Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 317)Lieferanten
Americas 1
China 272
Europe 1
France 2
Germany 3
India 3
Japan 1
United Kingdom 8
United States 26
Global 317
52286-59-6(2-O-(6-Desoxy-α-L-mannopyranosyl)-(3β,6α,12β)-20-(β-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl-β-D-glucopyranosid)Verwandte Suche:
chikusetsusaponinivc
b-D-Glucopyranoside, (3b,6a,12b)-20-(b-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl2-O-(6-deoxy-a-L-mannopyranosyl)-
(3β,6α,12β)-20-(β-D-Glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside
ginsenosideb2
GINSENOSIDE GINSENOSIDE-RE
GINSENOSIDE RE
2-O-(6-deoxy-alpha-L-mannopyranosyl)-(3beta,6alpha,12beta)-20-(beta-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl-beta-D-glucopyranoside
Ginsenoside Re std.
98%byHPLC/CH90650
Panaxoside
GINSENOSIDE RE WITH HPLC
GINSENOSIDE-RE (GINSENOSIDE B2)
NSC 308877
Sanchinoside Re
Panaxoside RE, Ginsenoside B2, Chikusetsusaponin IVc
glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl2-O-(6-deoxy-α-L-mannopyranosyl)-
β-D-Glucopyranoside,(3β,6α,12β)-20-(β-D-
[20-(β-D-Glucopyranosyloxy)-3β,12β-dihydroxy-5α-dammar-24-en-6α-yl]2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside
[20-(β-D-Glucopyranosyloxy)-3β,12β-dihydroxydammar-24-en-6α-yl]2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside
20-(β-D-Glucopyranosyloxy)-3β,12β-dihydroxy-5α-dammar-24-en-6α-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside
ginsenoside-Re standard
Ginsenoside Re ,97%
DCR-020
DCR-020;PANAXOSIDE RE;GINSENOSIDE B2;CHIKUSETSUSAPONIN IVC
Ginsenoside Re 52286-59-6
β-D-Glucopyranoside, (3β,6α,12β)-20-(β-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-
(2S,3R,4R,5R,6S)-2-(((1R,2S,3R,4R,6R)-6-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-((S)-1-hydroxy-5-methyl-1-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hex-4-en-1-yl)-4,4,8,10,14-pentamethylhexadecahydro-1H-cyclopenta[a]phenanthren-6-yl)oxy)-2,3-dihydroxy-4-(hydroxymethyl)cyclohexyl)oxy)-6-methyltetrahydro-2H-pyran-3,4,5-triol
(2S,3R,4R,5R,6S)-2-(((2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-((S)-6-methyl-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hept-5-en-2-yl)hexadecahydro-1H-cycl
(3beta,6alpha,12beta)-20-(beta-D-Glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-6-Deoxy-alpha-L-mannopyranosyl-beta-D-glucopyranoside
(2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol
4-?Dihydroxyphenyl)?ethanone
Ginsenoside Re (P)
(2S,3R,4R,5R,6S)-2-(((2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-Dihydroxy-4,4,8,10,14-pentamethyl-17-((S)-6-methyl-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hept-5-en-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-6-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-6-methyltetrahydro-2H-pyran-3,4,5-triol
Re
Ginsenoside Re
Ginsenoside Re(AS)
Ginsenoside Re-RM
β-?D-?Glucopyranoside, (3β,?6α,?12β)?-?20-?(β-?D-?glucopyranosyloxy)?-?3,?12-?dihydroxydammar-?24-?en-?6-?yl 2-?O-?(6-?deoxy-?α-?L-?mannopyranosyl)?-
52286-59-6
197-70-5
C48H82O18
Inhibitors
Ginsenoside series
chemical reagent
pharmaceutical intermediate
phytochemical
reference standards from Chinese medicinal herbs (TCM).
standardized herbal extract
The group of Ginsenosides
Saponins